Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 15, 2014

Dignify Receives SBIR Award for Bladder and Bowel Therapy

  • Dignify Therapeutics was awarded a $159,000  phase I Small Business Innovation Research (SBIR) grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (NIH).  

    Dignify is focused on restoring bladder and bowel control to people with spinal injury, spina bifida, and other neurological conditions with the aim of improving the quality-of-life for individuals that rely on bladder catheters and bowel programs for voiding. 

    “These funds will support the ongoing development of our lead product candidate, DTI-100, through the IND approval process and into clinical trials,” said Karl Thor, president and CSO.  “This SBIR award, together with future non-dilutive funding, will augment the Company’s current efforts to raise up to $3 million from private investors to develop DTI-100 through Phase II clinical trials.”   



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »